In its first month running at the University of Texas Medical Branch, a coronary calcium detection agent built on an FDA-cleared algorithm flagged a patient as being at imminent risk of a heart attack. Cardiology confirmed the risk and performed a triple bypass. That single case is the kind of story Bunkerhill Health is now taking to market after closing a $55 million Series B round to scale its agentic AI platform, Carebricks, across the US hospital system.
The round includes continued participation from Sequoia Capital, Felicis, Optum Ventures, and Y Combinator, with Khosla Ventures joining as a new investor. The funding arrives at a moment when US healthcare spending has hit $5.3 trillion and labor shortages continue to strain providers nationwide, according to the Centers for Medicare and Medicaid Services. Bunkerhill's argument to investors, and to the health systems already paying for the platform, is that Carebricks closes the space between a model that works in a sandbox and one that runs against live clinical data at institutional scale.
From Sandbox to Operating Room
Healthcare organisations have poured no shortage of funding behind machine learning pilots that perform well in a research setting and then never touch a live patient chart. Bunkerhill's thesis is that the next round of technology spending goes toward software that acts on the ideas clinicians already have, rather than just recording them. Carebricks lets hospitals build their own AI agents rather than buying a fixed product off the shelf. Some agents review cardiology imaging for early signs of heart disease and flag patients who need follow-up care. Others handle prior authorisations or keep registry data current. The range extends into administrative work that rarely gets attention in AI pitches but consumes staff hours every week.
Nishith Khandwala, Co-Founder and CEO of Bunkerhill Health, put it directly: "Medicine has advanced faster than our healthcare system's ability to operationalise it. Every leading health system has more opportunities to improve patient outcomes than its workforce has capacity to address. We believe AI agents can help them turn more of those ideas into reality."
Twenty Agents, One Health System
UTMB offers the clearest picture of what running agentic AI at hospital scale looks like once the pilot label comes off. The system now has more than 20 agents live on Carebricks, spanning clinical care, operations, and administration, according to Dr. Peter McCaffrey, UTMB's Chief AI Officer.
Beyond the coronary calcium detection case, a nephrology triage agent now prioritises patients by severity, escalating urgent cases and routing others to telemedicine. UTMB reports this has cut average specialist wait times by more than 50 percent. A lung nodule agent tracks incidental findings on CT scans through to the correct follow-up, with UTMB citing an 80 percent faster response on urgent cases and a doubling of guideline-concordant follow-up alongside a drop in manual coordinator work. Cleveland Clinic and Intermountain Health also run the platform today.
These are health system-reported operational results from live production use, not synthetic benchmark scores, which matters. It also means the numbers reflect one institution's data conditions and staffing setup, not a guarantee that another hospital will see the same curve. But for a sector that has spent years searching for proof that AI can function inside a working hospital rather than a research paper, UTMB's 20-agent footprint gives Bunkerhill a reference case few competitors can currently match.
Why Investors Are Betting on Deployment, Not Technology
Vinod Khosla, Founder of Khosla Ventures, made the investment thesis plain: "The bottleneck in healthcare AI was never the technology, it was getting a health system to actually run it. Bunkerhill closed that gap. They made it much, much easier to adopt AI and already have traction inside critical health systems that would take most companies years to earn."
The emphasis on deployment rather than model performance is telling. Across healthcare AI, the companies winning the largest rounds in 2026 are not those with the best benchmarks but those that can demonstrate real revenue from real hospitals. Bunkerhill's Series B follows that pattern. The company says it will use the new funding to expand Carebricks into a wider range of clinical and operational use cases while building out governance, monitoring, and safeguards.
A platform that lets a nephrology department build its own triage agent also means that department owns the consequences of how that agent is tuned. Health system boards weighing a Carebricks-style deployment need answers on liability assignment, monitoring cadence, and what happens when an agent's judgment and a clinician's judgment disagree, before signing off on scale. Those questions do not have industry-wide answers yet, and Bunkerhill's real work in the coming quarters may be as much about governance as it is about engineering.
What Comes Next for Hospital AI Agents
The $55 million round positions Bunkerhill as one of the better-funded players in the agentic healthcare AI space, but it is far from alone. Health systems are being pitched by dozens of companies offering AI agents for everything from revenue cycle management to clinical decision support. Bunkerhill's differentiation lies in its agent-building approach rather than a fixed product, and in reference accounts that can point to specific clinical outcomes rather than vague efficiency claims.
UTMB's 20-agent footprint gives Bunkerhill a credible starting point. Whether that number holds up as a signal for the rest of the industry depends on how UTMB, and the other systems now running Carebricks, handle the governance side as the agent count climbs. For founders building in healthcare AI, the signal from this round is clear: investors are willing to write large checks, but only for companies that have already crossed the gap from pilot to production inside a real hospital. Bunkerhill has done that. The question now is whether it can help the rest of the industry do the same without cutting corners on the safeguards that make hospital AI safe enough to trust with a patient's life.